Marie-Claude Potier, PhD, Pharm. D.

Co-Group Leader of “Alzheimer’s and Prion Diseases” group

ICM-Brain & Spine Institute, Paris, France

 Dr. Marie-Claude Potier is Director of Research at the French National Center for Scientific Research (CNRS) and Co-Group Leader of the “Alzheimer’s and Prion Diseases” research group at Paris Brain Institute, ICM at the Pitié-Salpêtrière Hospital, Paris, France.

After a PharmD in Neuropharmacology at the University Réné Descartes, Paris, France and a PhD at the University Pierre and Marie Curie, Paris, France, she was trained in molecular and cellular biology during three years post-doct at the MRC Laboratory of Molecular Biology, Cambridge, UK. She returned to the Alfred Fessard Institute when she obtained a permanent scientific staff position at CNRS and later joined the School of Physic & Chemistry (ESPCI), Paris France. She lately joined the ICM in 2008.

Dr. Marie-Claude Potier has been working for the past twenty-five years on Down syndrome (DS) and is now developing pharmacological treatments for increasing cognition in DS as well as studying early phenotypes of Alzheimer disease in DS.

Dr. Marie-Claude Potier published 140 papers in scientific journals and is since 2017 Corresponding Member of the French Academy of Medicine. She received the Dagnan-Bouveret Prize from The French Science Academy in 2005. She served as the General Secretary of T21RS and is now member of the Preclinical and the Sponsoring committees.